A bipartisan coalition of 50 states, D.C., and two territories reached settlements with Heritage Pharmaceuticals, Inc. and Apotex Corp. to resolve allegations of price fixing generic drugs in violation of the Sherman Act. As part of complaints filed in 2017 and 2019, the AGs allege that the companies, along with other drug manufacturers and their executives,…

Read More

Connecticut AG William Tong obtained a judgment in his favor in his office’s lawsuit against Assured Rx, LLC (“Assured”), which alleged that the pharmacy engaged in a kickback scheme in violation of  state false claims and anti-kickback statutes. According to the AG’s office, the complaint alleged that Assured orchestrated a scheme in which retired state employees…

Read More

New Jersey AG Matthew Platkin announced the adoption of new rules designed to promote greater transparency in prescription drug pricing. The new rules implement recently enacted legislation intended to control prescription costs by imposing registration, reporting, and compliance requirements on manufacturers, insurance carriers, wholesalers, and other entities, who will be required to provide the AG’s office with…

Read More

A group of 21 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the Ninth Circuit supporting Oregon in its defense of H.B. 4005, which requires pharmaceutical manufacturers to report certain information about specific new prescription drugs and historical information about pricing for existing drugs. The U.S. District Court for the District of Oregon had…

Read More

California AG Rob Bonta issued letters to eight large pharmacy chains and five health data companies reminding the companies of their obligations to comply with California’s Confidentiality of Medical Information Act (CMIA) and new requirements from Assembly Bill (AB 352), that went into effect on July 1, 2024. The letters remind the pharmacies that the CMIA prohibits…

Read More